GB201616093D0 - Pharmaceutical composition

Pharmaceutical composition

Info

Application number

GBGB1616093.9A

Current Assignee

Coegin Pharma AS

Original Assignee

Avexxin AS

Priority date

2016-09-21

Filing date

2016-09-21

Publication date

2016-11-02

2016-09-21 Application filed by Avexxin AS filed Critical Avexxin AS

2016-09-21 Priority to GBGB1616093.9A priority Critical patent/GB201616093D0/en

2016-11-02 Publication of GB201616093D0 publication Critical patent/GB201616093D0/en

2017-09-21 Priority to CN201780057936.XA priority patent/CN109789111B/en

2017-09-21 Priority to US16/334,835 priority patent/US11351127B2/en

2017-09-21 Priority to EP17778235.6A priority patent/EP3515422A1/en

2017-09-21 Priority to CA3037582A priority patent/CA3037582A1/en

2017-09-21 Priority to JP2019536703A priority patent/JP2019529555A/en

2017-09-21 Priority to PCT/EP2017/073958 priority patent/WO2018055062A1/en

2017-09-21 Priority to AU2017329957A priority patent/AU2017329957B2/en

2017-09-21 Priority to KR1020197010816A priority patent/KR20190055153A/en

2019-03-18 Priority to IL265428A priority patent/IL265428A/en

Status Ceased legal-status Critical Current

GBGB1616093.9A 2016-09-21 2016-09-21 Pharmaceutical composition Ceased GB201616093D0 (en)